NYSE:MRT

MedEquities Realty Trust (MRT) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.58
$1.76
50-Day Range
$11.03
$11.03
52-Week Range
$6.27
$11.85
Volume
249,276 shs
Average Volume
568,366 shs
Market Capitalization
$95.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.90
MRT stock logo

About MedEquities Realty Trust Stock (NYSE:MRT)

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility-based providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment.

MRT Stock News Headlines

Urgent Nvidia Warning
Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
Marti Announces Full Year 2023 Results
Independence Realty Trust Inc.
Urgent Nvidia Warning
Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
Morguard Real Estate Investment Trust MRT.UN
Digital Realty Trust Inc DLR
Marti Announces up to $2.5M Share Repurchase Program
Arbor Realty Trust Inc ABR
See More Headlines
Receive MRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedEquities Realty Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/08/2018
Today
5/03/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Automotive rental & leasing, without drivers
Sub-Industry
N/A
Fax
N/A
Employees
11
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$0.90
High Stock Price Target
$0.90
Low Stock Price Target
$0.90
Potential Upside/Downside
-47.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20.03 million
Book Value
($0.57) per share

Miscellaneous

Free Float
55,325,000
Market Cap
$96.97 million
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. John W. McRoberts (Age 66)
    Chairman & CEO
  • Mr. William C. Harlan (Age 67)
    Pres, COO & Director
  • Mr. Jeffery C. Walraven (Age 49)
    Exec. VP, CFO, Sec. & Treasurer
  • Mr. David Louis Travis (Age 44)
    Sr. VP & Chief Accounting Officer
  • Mr. Tripp Sullivan
    Investor Relations, SCR Partners, LLC

MRT Stock Analysis - Frequently Asked Questions

Should I buy or sell MedEquities Realty Trust stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MedEquities Realty Trust in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MRT shares.
View MRT analyst ratings
or view top-rated stocks.

What is MedEquities Realty Trust's stock price target for 2024?

1 brokers have issued 1-year price targets for MedEquities Realty Trust's stock. Their MRT share price targets range from $0.90 to $0.90. On average, they anticipate the company's stock price to reach $0.90 in the next year. This suggests that the stock has a possible downside of 47.1%.
View analysts price targets for MRT
or view top-rated stocks among Wall Street analysts.

How were MedEquities Realty Trust's earnings last quarter?

MedEquities Realty Trust Inc (NYSE:MRT) released its quarterly earnings data on Wednesday, August, 8th. The financial services provider reported $0.10 EPS for the quarter, missing the consensus estimate of $0.30 by $0.20. The financial services provider had revenue of $17.56 million for the quarter, compared to the consensus estimate of $17.03 million.

What guidance has MedEquities Realty Trust issued on next quarter's earnings?

MedEquities Realty Trust updated its FY 2024 earnings guidance on Tuesday, April, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $16.6 million-$16.6 million.

What other stocks do shareholders of MedEquities Realty Trust own?
When did MedEquities Realty Trust IPO?

MedEquities Realty Trust (MRT) raised $259 million in an IPO on Thursday, September 29th 2016. The company issued 19,900,000 shares at a price of $12.00-$14.00 per share. FBR, J.P. Morgan, Citigroup, KeyBanc Capital Markets, Raymond James and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities, Fifth Third Securities and Capital One Securities were co-managers.

This page (NYSE:MRT) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners